[Retracted] Clinical Nursing Paths Benefit Patient Outcomes Undergoing Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

Table 3

The incidence of adverse reactions, length of hospital stay, and hospitalization costs between both groups.

	CNP group (n = 48)	Control group (n = 41)	t or χ^2	P
Gastrointestinal reaction	1 (2.08%)	2 (4.88%)
Nausea and vomiting	1 (2.08%)	1 (2.44%)
Liver pain	0 (0.00%)	2 (4.88%)
Urinary retention	0 (0.00%)	1 (2.44%)
Fever	1 (2.08%)	2 (4.88%)
Bleeding	0 (0.00%)	1 (2.44%)
Total incidence	3 (6.25%)	9 (21.95%)	4.673	0.031
Length of hospital stay	10.03 ± 1.51	12.32 ± 2.68	5.04	<0.001
Hospitalization costs	4989.33 ± 116.20	6209.52 ± 163.78	40.77	<0.001